New Results on Treatment of Metastatic Breast Cancer - European Cancer Congress (ESMO) 2023

UCSF Bay Area Breast Cancer Forum: Updates from ESMO 2023Подробнее

New Results on Treatment of Gynaecological Cancers - European Cancer Congress (ESMO) 2023Подробнее

New Results for Treatment of Non-Metastatic Stomach Cancer - European Cancer Congress (ESMO) 2023Подробнее

Oncology As On Today : Essence Of ESMO & Other Major Conference : 2023Подробнее

New Results on Treatment of Melanoma - European Cancer Congress (ESMO) 2023Подробнее

New Results on Treatment of Advanced Lung Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results for Treatment of Metastatic Stomach Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results on Treatment of Supportive Therapies - European Cancer Congress (ESMO) 2023Подробнее

New Results for Treatment of Colon Cancer - European Cancer Congress (ESMO) 2023Подробнее

69. ESMO 2023 - Metastatic Breast CancerПодробнее

#ESMO21 Expert Video Report on HER2-positive metastatic breast cancerПодробнее

Highlights on Lu-PSMA-617 in taxane-naive patients with mCRPC: The PSMAfore studyПодробнее

Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2Подробнее

ESMO 2023 Breast Cancer Highlights – Keynote 756, TROPION-Breast01, Keynote 52 | Onc BrothersПодробнее

Immutep (ASX:IMM, NASDAQ:IMMP) ESMO Congress results webinar, 23 October 2023Подробнее

Expert report on treatment with Tumour-Infiltrating Lymphocytes (TILs)Подробнее

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment ArsenalПодробнее

Immutep (ASX:IMM) ESMO Congress results webinar, October 2023Подробнее

New Results on Treatment of Early Lung Cancer - European Cancer Congress (ESMO) 2023Подробнее